| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Counted by filing, the last 12 months brought no open-market purchases and 34 sales by 12 insiders worth about $22.1M. The 12 months before that brought no open-market purchases and 20 sales by 11 insiders worth about $13.2M.
15 of the 34 sales in the last 12 months were made under a Rule 10b5-1 trading plan; the rest were not.
No open-market purchase by an insider appears in the QURE Form 4 filings on record.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 519.2K | $12.39M | - | |
| CFO | 226.6K | $5.41M | - | |
| Other | 167.0K | $3.99M | - | |
| Other | 133.2K | $3.18M | - | |
| Other | 108.9K | $2.60M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Matthew C Kapusta64 | CEO, Managing Director | Sale+OE10b5-1 | 21,082 | $45.16 | $952,051.26 | -3.9% | -42.2% | - | |
| Jun 30, 2026 | Jack Kaye52 | Director | Sale+OE10b5-1 | 21,167 | $46.44 | $983,030.23 | -44.9% | -15.1% | - | |
| Jun 30, 2026 | Walid Abi-Saab | Chief Medical Officer | Sale+OE10b5-1 | 30,000 | $46.42 | $1,392,600.00 | -16.8% | -15.1% | - | |
| Jun 26, 2026 | Walid Abi-Saab | Chief Medical Officer | Sell | 1,434 | $46.86 | $67,197.24 | -0.8% | -19.3% | - | |
| Jun 25, 2026 | Matthew C Kapusta64 | CEO, Managing Director | Sale+OE10b5-1 | 35,412 | $50.02 | $1,771,174.32 | -6.4% | -12.9% | - | |
| Jun 18, 2026 | Matthew C Kapusta64 | CEO, Managing Director | Sale+OE10b5-1 | 206,100 | $45.47 | $9,371,611.75 | -28.3% | -8.2% | - | |
| Jun 17, 2026 | Jack Kaye52 | Director | Sale+OE10b5-1 | 5,295 | $42.57 | $225,408.15 | -16.9% | -10.5% | - | |
| Jun 17, 2026 | Madhavan Balachandran51 | Director | Sale+OE10b5-1 | 11,685 | $45.06 | $526,484.60 | -21.3% | -10.5% | - | |
| Jun 15, 2026 | Jeannette Potts | Chief Legal Officer | Sell | 5,237 | $27.67 | $144,907.79 | -3.8% | +61.2% | - | |
| Jun 15, 2026 | Madhavan Balachandran51 | Director | Sale+OE10b5-1 | 10,000 | $27.85 | $278,500.00 | -18.8% | +61.2% | - |